A detailed history of Wimmer Associates 1, LLC transactions in Novartis Ag stock. As of the latest transaction made, Wimmer Associates 1, LLC holds 3,064 shares of NVS stock, worth $301,344. This represents 0.18% of its overall portfolio holdings.

Number of Shares
3,064
Previous 3,064 -0.0%
Holding current value
$301,344
Previous $326,000 7.98%
% of portfolio
0.18%
Previous 0.17%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$92.57 - $107.37 $3,239 - $3,757
35 Added 1.16%
3,064 $326,000
Q4 2023

Feb 14, 2024

SELL
$92.27 - $101.54 $16,147 - $17,769
-175 Reduced 5.46%
3,029 $305,000
Q3 2023

Nov 14, 2023

BUY
$94.73 - $105.13 $3,789 - $4,205
40 Added 1.26%
3,204 $326,000
Q2 2023

Aug 14, 2023

BUY
$92.52 - $104.91 $9,252 - $10,491
100 Added 3.26%
3,164 $319,000
Q1 2023

May 16, 2023

BUY
$80.03 - $92.81 $67,545 - $78,331
844 Added 38.02%
3,064 $281,000
Q4 2022

Feb 14, 2023

BUY
$75.55 - $92.52 $167,721 - $205,394
2,220 New
2,220 $201,000
Q2 2022

Aug 12, 2022

SELL
$80.52 - $93.75 $189,302 - $220,406
-2,351 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$80.11 - $90.62 $188,338 - $213,047
2,351 New
2,351 $206,000
Q1 2020

May 15, 2020

SELL
$70.67 - $99.01 $162,541 - $227,723
-2,300 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$84.35 - $95.37 $194,005 - $219,351
2,300 New
2,300 $218,000
Q3 2019

Nov 14, 2019

SELL
$85.54 - $94.26 $348,661 - $384,203
-4,076 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$75.4 - $92.8 $6,409 - $7,888
-85 Reduced 2.04%
4,076 $372,000
Q3 2018

Nov 13, 2018

SELL
$66.94 - $77.43 $16,534 - $19,125
-247 Reduced 5.6%
4,161 $359,000
Q2 2018

Aug 14, 2018

SELL
$64.91 - $73.36 $584 - $660
-9 Reduced 0.2%
4,408 $333,000
Q3 2017

Nov 14, 2017

SELL
$74.14 - $77.27 $37,070 - $38,635
-500 Reduced 10.17%
4,417 $379,000
Q2 2017

Aug 14, 2017

BUY
N/A
4,917
4,917 $410,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Wimmer Associates 1, LLC Portfolio

Follow Wimmer Associates 1, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wimmer Associates 1, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wimmer Associates 1, LLC with notifications on news.